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ABSTRACT 
Introduction: Health disparities are a major public health concern. Researchers often seek 
to explain whether these disparities are attributable to modifiable downstream risk factors that 
are also predictive of outcomes. Traditionally-used mediation approaches may not be appropriate 
to explain such disparities, due to the complex nature of socio-demographic factors such as 
race/ethnicity.  
Methods: Aim 1: We carried out a methodological review of the literature. We searched 
for studies that investigated a racial/ethnic disparity in a health outcome and adjusted for a 
potential modifiable mediator of the disparity. Out of the 969 studies meeting inclusion criteria, a 
simple random sample of fifty studies were drawn to undergo thorough data abstraction. Data 
were abstracted to determine what mediation approaches were employed, if causal language was 
used to describe these estimates, and if relevant assumptions were considered in justifying this 
causal language. Aim 2: We also carried out an analysis of National Survey of Family Growth 
(NSFG) data representing 103,919,318 live singleton births to mothers in the United States. This 
analysis employed traditional (Difference and Product methods) and general mediation methods 
(Inverse Probability-Weighted Marginal Structural Models and Structural Transformation) to 
result in different estimates of how payment method for delivery explained the racial/ethnic 
disparity in low birth weight. 
Ashley I. Naimi, PhD 
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Loren J. Schleiden, MS 
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Results: All studies included in the target review employed traditional mediation 
approaches, the majority used language that could be interpreted as causal (86%), and none of 
the studies explicitly addressed assumptions or conditions for interpreting estimates causally. In 
the analysis of NSFG data, for every 100 births, there were an additional 5.27 low birth weight 
infants born to non-Hispanic Black mothers, compared to births to non-Hispanic White mothers. 
Estimates of the counterfactual disparity measure ranged from 1.62 using the product method to 
4.66 using the structural transformation method.  
Conclusion: Traditional mediation approaches are commonly used to explain 
racial/ethnic disparities. The use of such traditional approaches to explain disparities along the 
lines of complex socio-demographic variables may be inappropriate due to underlying 
assumptions that are likely broken. Considerations of these underlying assumptions and use of 
appropriate mediation approaches are crucial to understanding the important public health issue 
of health disparities. 
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1.0  INTRODUCTION 
The Problem of Health Disparities   
Health disparities are among the most salient public health concerns in the United States. 
Cancer, HIV/AIDS, homicide, cardiovascular, reproductive, and pediatric health outcomes are 
all strongly patterned along socio-demographic lines, with disadvantaged populations carrying a 
disproportionate disease burden.1 Such socio-demographic factors that distinguish advantaged 
from disadvantaged populations include (but are not limited to) sex/gender, sexual orientation, 
education, income, occupation, and race/ethnicity. These socio-demographic factors have been 
deemed “upstream” because they are thought to influence more proximal (“downstream”) 
determinants of health that include health behaviors, stress, and access to care, which 
subsequently pattern health outcomes.2  
Despite many of these health disparities being long-demonstrated, intervening to reduce 
such disparities is difficult. Health disparities are multifaceted and can thus be impacted by the 
interplay of a multitude of social determinants. Contemporary social determinants are seen as the 
result of a long history of social processes and institutional mechanisms. Many of these 
disparities are nuanced and may not be appropriately captured through the convenience measures 
that are often used to report them. Due to their complex nature, it can be impossible to fully 
understand health disparities, much less to implement interventions that fully address them. As a 
result, many health disparities that have been observed for decades persist, and there have 
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recently been calls for further research and policy changes.3 Healthy People 2020 has made it an 
overarching goal to “achieve health equity, eliminate disparities, and improve the health of all 
groups,”4 and reducing disparities is a core objective of the Patient Protection and Affordable 
Care Act (ACA; Pub L No. 11-148). 
“Explaining” Health Disparities  
Addressing the nature of health disparities is crucial. To that end, there is a large, long-
standing, and continually growing body of research devoted to “explaining” why health 
disparities exist. This work often seeks to account for the extent to which an overall statistical 
association between a health disparity marker and health outcome is attributable to other factors.  
For example, a 2007 study of data from the National Health and Nutrition Examination Surveys 
attempted to “explain” excess hypertension risk among African Americans and US-born 
Hispanics (compared to Whites) by controlling for measures of socioeconomic status (education, 
household income, and poverty income ratio), health behavior (lack of exercise, current smoking, 
and poor diet), and access to care (current health insurance availability).5 In this study, 
researchers sought to evaluate how much the racial/ethnic disparity in hypertension risk was 
attributable to the corresponding racial differences in these downstream factors (socioeconomic 
status, health behavior, and access to care). 
Due to the complex nature of these socio-demographic factors, typical markers of a given 
health disparity, such as race/ethnicity, cannot be interpreted as corresponding to some well-
defined intervention. However, social, clinical, and/or public health policy changes may be able 
to target modifiable “downstream” factors that act as proximal risk factors that play a role in 
transmitting the association between the health disparity marker (exposure) and outcome. For 
example, a systematic review of interventions targeting racial/ethnic disparities in diabetes risk 
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presented patient interventions targeting potentially modifiable downstream risk factors such as 
dietary habits, physical activity, and diabetes self-management activities.6 The broader goal of 
this type of research is to influence policy change, resulting in interventions that can lead to a 
reduction in health disparities. However, it is important that these policy changes are informed 
by best research practices. In order to develop useful empirical evidence, researchers must use 
analytic methods that properly answer pertinent clinical and public health questions.  
Mediation Analysis 
Questions pertaining to the extent to which a health disparity is “explained” by a 
modifiable downstream risk factor are fundamentally questions about mediation. Mediation 
analysis refers to a set of analytic techniques that enable researchers to evaluate the processes or 
mechanisms by which an exposure is associated with an outcome. A common approach to 
explaining health disparities has sought to identify modifiable mediators, which, if altered, will 
lead to a reduction in health disparities. This approach is based on the presumption that the 
information obtained will valuably contribute evidence on whether an available intervention 
should be used to reduce health disparities and improve overall health. This presumption requires 
a logical correspondence between the research question, analytic method, and the potential 
clinical or public health interventions. The common objective of all such analyses is thus to 
determine whether an intervention targeting the mediator in question will make a viable and 
worthwhile impact. 
Despite this common objective, a multitude of disparate analytic approaches have been 
used to quantify the extent to which mediators explain health disparities. These approaches 
involve an attempt to either: (1) decompose the effects into direct and indirect components; or 
(2) quantify the disparity that would remain if the mediator were set at a single value within a 
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population. The direct exposure effect represents the effect of the exposure on the outcome that 
does not operate through a mediator [e.g., the effect of race/ethnicity (exposure) on hypertension 
(outcome) risk independent of income (mediator)]. The indirect exposure effect quantifies the 
effect of the exposure on the outcome that operates through the exposure’s impact on a mediator 
[e.g. the effect of race/ethnicity (exposure) on hypertension risk (outcome) through its impact on 
income (mediator)]. These are distinct from the effect that would remain if the mediator were set 
to a specific value uniformly in the population. 
The Difference Method 
Although a large number of analytic techniques are available to conduct mediation 
analysis, researchers often rely on a select few. One technique known as the “difference method” 
has long been used as a template to conduct such analyses. With the difference method, the effect 
of an exposure on an outcome without adjusting for a mediator (illustrated as c in Figure 1) is 
compared to the exposure’s effect after adjusting for a mediator (illustrated as c’ in Figure 1). 
Regarding two linear regression models of the outcome (Y) that include the exposure (X), with 
one model not adjusting for the proposed mediator(s) (M) and another model adjusting for M: 
1. Y = β2 + cX + ε1 
2. Y = β3 + c’X  + bM + ε2 
Figure 1. Difference Method Mediation Model 
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According to the difference method, the difference in the effect of the exposure on the 
outcome before and after adjusting for the mediator(s) (coefficients c and c’ in the equations 
above) is considered to be the indirect effect (i.e., effect of the exposure that operates through the 
mediator), while the effect that remains after adjusting for the mediator is considered the direct 
effect (i.e., the effect of the exposure that does not operate through the mediator). In practice, the 
difference method will only provide valid results under linear regression models and under 
stringent no confounding and no interaction conditions (discussed further later). However, non-
linear regression methods (e.g., logistic, Cox proportional hazards) are often used, and the 
conditions are often ignored. 
The Product Method 
Similar to the difference method is the “product method” initially proposed by Baron and 
Kenny.7 According to Google Scholar, Baron and Kenny’s 1986 methodological paper on the 
moderator-mediator variable distinction has been cited 62,558 times, which speaks to how 
widely the product method has been used in the literature. In Figure 1, the product method is 
depicted as decomposing effects into the direct effect (c) and indirect effect (product of 
coefficients a and b). 
According to the product method, mediation can be evaluated using three regression 
models (equations shown below, where a, b, c, and c’ correspond to the Figure 1 above): 1) a 
model of the exposure predicting the outcome; 2) a model of the exposure predicting the 
mediator; and 3) a model of the exposure predicting the outcome while adjusting for the 
mediator:  
1. Y = β1 + cX + ε1 
2. M = β2 + aX + ε2 
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3. Y = β3 + c’X  + bM + ε3 
According to the product method, significant associations need to be confirmed between 
the exposure and outcome in the unadjusted model predicting the outcome (c), between the 
exposure and mediator in the model predicting the mediator (a), and between the mediator and 
outcome in the model including the exposure and mediator predicting the outcome (b). A 
decrease in the association between the exposure and outcome going from the model that does 
not include the mediator (c) to the model adjusting for the mediator (c’) is taken as evidence of 
mediation.  
Problems of the Difference and Product Methods 
While the difference method and product method seem intuitive, closer scrutiny suggests 
that they cannot be used to analyze health disparities. A health disparity is defined as a 
comparison (e.g., difference, ratio) of the measure of occurrence between two groups identified 
by some characteristic. For example, black men are at 1.23 times the risk of heart disease of 
white men in the United States.8  Such a quantity can be estimated using standard unadjusted 
regression without issue. However, when researchers seek to “explain” health disparities, the 
target quantity of interest is often framed as an answer to questions such as: what would the 
magnitude of the disparity be if some downstream risk factor were held constant at a specified 
value? 
 
Figure 2. Mediation Diagram with Measured Confounder of the Mediator-Outcome (Cmy) 
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 This question can be answered by quantifying the red arrows in Figure 2. This figure 
shows the relations between the sociodemographic characteristic of interest (X), the downstream 
risk factor (M) and outcome (Y) under study, and confounders of the relation between the 
downstream risk factor and the outcome (CMY). In this figure, the disparity that would remain if 
the downstream risk factor were set to a specific level is represented by all (red) arrows 
emanating from X that are not transmitted though M (i.e., X → Y and X → CMY → Y).  
To quantify the racial/ethnic disparity that would remain if M were intervened upon using 
standard approaches (difference or product methods), several strong assumptions are required. 
These include:9 
 1. No uncontrolled mediator-outcome confounding 
 2. No exposure-mediator interaction on the scale of interest 
 3. No mediator-outcome confounders affected by the exposure  
The single-most important complication that arises when seeking to quantify the extent to 
which a health disparity is explained by a downstream risk factor is the violation of assumption 
3, represented by the X → CMY relation in Figure 2. Socio-demographic characteristics denoted 
X in the figure (e.g., race/ethnicity) are deemed “upstream” precisely because they are associated 
with a wide range of risk factors. These risk factors include the primary intervention variable of 
interest M, as well as any variables that confound the M→Y relation (CMY). Because these latter 
variables are confounders, they must be adjusted for in any analyses seeking to quantify the 
disparity that would remain if M were set to a specific level in the population. However, 
adjusting for them using standard techniques such as the difference or product methods will also 
block part of the association of interest (i.e., X → CMY → Y). This issue represents a 
fundamental analytic challenge in explaining health disparities. 
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Additionally, controlling for this mediator-outcome confounder via standard regression 
methods in the presence of further unmeasured confounding between this confounder and the 
outcome would induce a collider bias, opening a pathway from exposure to the outcome (X → 
CMY ← U → Y in the figure above). Collider bias can occur when conditioning on a variable that 
is an outcome of both the exposure and the outcome, and it has the opposite effect of 
conditioning on a non-collider: conditioning on a non-collider blocks the flow of association 
along a path, while conditioning on a collider opens the flow of association.10 Finally, the 
presence of an exposure-mediator interaction, thus violating assumption 3, could render causal 
inferences made through the difference method invalid. Exposure-mediator interaction makes it 
impossible to measure a single direct effect, because the direct effects vary by different levels of 
the mediator.  
Importantly, the violations of each of these assumptions is highly likely in a health 
disparities setting due to the nature of sociodemographic variables, and the structural relations 
that exist, as demonstrated in Figure 1. Consequently, despite their frequent use, the difference 
and product methods are inappropriate for answering key questions of interest health disparities 
research. 
An additional complication arises with use of the difference and product methods. When 
using an association measure that is non-collapsible, such as an odds ratio or hazard ratio, the 
unadjusted odds ratio or hazard ratio cannot be compared to an odds ratio or hazard ratio that has 
been adjusted for a mediator.11 This may be more problematic when considering a dichotomous 
outcome that is common, as the impact of non-collapsibility is more severe. 12 There do exist 
circumstances in which the difference method and the product method yield valid causal effects. 
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But the assumptions required are strong and unverifiable. It is thus not possible for investigators 
and readers of the health disparities literature to know when these assumptions have been met. 
General Mediation Approaches 
Other approaches to mediation analysis have recently been developed, many of which 
overcome the limitations of the difference method and product methods. Inverse probability-
weighted marginal structural models (IPW MSMs) have been proposed as a mediation method 
that can be used to properly adjust for mediator-outcome confounders associated with the 
exposure.13 By generating inverse probability weights from models of the mediator and fitting a 
weighted regression model of the outcome that includes the exposure, mediator, and their 
interaction, mediator-outcome confounders can be properly accounted for. Structural 
transformation accounts for confounding through first modeling the mediator. This model can 
provide an unbiased estimate of the mediation effect. From this model, parameters of the 
mediator and exposure-mediator interaction term are subtracted from the outcome to create a 
transformed outcome. In effect, this act of transforming the outcomes removes the effect of the 
mediator. The outcome is then modeled against the exposure to estimate the effect of the 
exposure on the outcome, with the effect of the mediator removed. G-estimation of a structural 
nested mean model14 and targeted minimum loss-based estimation (TMLE)15 each model both 
the mediator the outcome model, and combine these models to yield doubly robust estimators, 
which are consistent if either the mediator or outcome (but not necessarily both) model is 
correctly specified.16-18   
Considering Mediation Techniques in Analysis of Racial/Ethnic Disparities 
The distinctions between the difference or product methods and more general approaches 
can have important consequences on research findings. Indeed, using these various mediation 
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analysis techniques can produce widely varying results. As shown by Naimi et al, using the 
difference method and generalized product method versus more advanced methods (IPW MSMs, 
structural transformation, g-estimation, and TMLE) resulted in drastically different estimates of 
the counterfactual disparity measure. Estimates of the proportion of the disparity explained 
ranged from 126% using the difference method to 8% using structural transformation.19  
The overarching goal of many health disparities investigators is to influence policy 
changes at the health system, government, and societal levels to reduce disparities and improve 
health outcomes. When spurious results are presented as causal effects, even though the criteria 
for making a causal statement have not been met or considered, the influence on policy change 
could lead to ineffective interventions, waste of resources, and further confusion on the already 
complex nature of health disparities.  
Racial Disparities in the United States 
To better focus the remainder of the current work, the state of the research on racial 
disparities in health in the United States will be considered. Race/ethnicity is a non-modifiable 
socio-demographic factor along which a multitude of health disparities have been patterned. 
Various studies have sought to explain racial/ethnic disparities using proposed mediators.20-22 
The crucial roles that race/ethnicity play in health outcomes demand that it continue to be 
addressed through research and policy change, but researchers often fail to consider the 
approaches and analytic methods that are appropriate in estimating  the role of mediators in these 
disparities. Racial/ethnic health disparities in the United States are pervasive and severe, with 
national disparities by race/ethnicity in infant mortality,23 heart disease,24 cancer,20,25,26 HIV,27 
and life expectancy.28 As such, race/ethnicity is one of the most salient socio-demographic 
factors in the United States, and it will be the focus of this thesis.  
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Objectives 
The objective of this thesis is two-fold: Aim 1of the thesis is to conduct a targeted review 
of the literature in order to describe the analytic strategies used to quantify the extent to which 
racial/ethnic health disparities are explained by more proximal risk factors. This review will 
focus on the following research questions: 1) what analytic techniques are being used to quantify 
the effect of proximal risk factors in racial/ethnic health disparities?; 2) what effect estimates are 
being reported, and were techniques used appropriate for reporting such effects?; and 3) were 
causal explanations implied in the language used to describe different effect estimates, and was 
this use justified? No such targeted review of the literature has been published.  
The objective of Aim 2 is to conduct an analysis using traditional and general mediation 
approaches to quantify the same target quantity. This will demonstrate how applying different 
mediation approaches can result in a range of estimates of the mediation effect when applied to a 
question of racial/ethnic disparity. The National Survey of Family Growth (NSFG) will be used 
to answer the research question “how much does payment method explain the racial disparity in 
low birth weight births?” This research question will be answered using traditional (difference 
method and product method) and general (IPW MSMs and structural transformation) mediation 
approaches to determine estimates of the counterfactual disparity measure and proportion of the 
disparity explained. The counterfactual disparity measure (CDM) can be interpreted as the 
magnitude of the disparity if, contrary to fact, the mediator could be set to a certain level. 
Proportion explained is the estimate of the proportion of the total effect of the exposure on the 
outcome that is explained by a mediator. 
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2.0  METHODS 
Aim 1 - Target Review 
The targeted review was conducted in accordance with a prospective protocol designed 
for this study. This protocol was in part guided by a Public Health Informationist at the 
University of Pittsburgh Health Sciences Library System (HSLS). Inclusion criteria were 
established by authors LS and AN based on preliminary searches. Five exemplar studies meeting 
inclusion criteria were determined and checked for in all searches. The abstracts of final results 
were inspected by one reviewer to determine evidence of inclusion criteria, with full texts being 
consulted for any results that could not be determined through abstract review alone. Inclusion 
criteria were verified by a second reviewer for 10% of final results. Pertinent information was 
abstracted from full texts for a simple random sample of 50 articles meeting inclusion criteria. 
Inclusion Criteria 
 Studies were considered to have met inclusion criteria if they: 1) investigated at least one 
racial and/or ethnic disparity in a health condition, service, treatment, or outcome; 2) adjusted for 
a variable or group of variables interpreted as modifiable mediator(s) of the measure of 
race/ethnicity and outcome association (i.e, race/ethnicity is associated with a mediator 
variable(s), which in turn impacts the outcome, thus “explaining” at least a proportion of the 
association between race/ethnicity and outcome); and 3) were published between 01/01/2000 and 
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05/18/2016. Reviews or meta-analyses without original data, case series or reports, comments, 
letters to the editor, and editorials were excluded from the review. 
Identification of Studies 
 A search was conducted by the investigators in PubMed combining general and key word 
terms pertaining to mediation analyses, race/ethnicity, and disparities, informed in part by 
Medical Subject Heading (MeSH) terms. Terms for mediation analysis included mediation 
analy*, mediator analy*, controlled direct, natural direct, natural indirect, natural effect, direct 
effect, proportion explain*, and explain*. Terms for race/ethnicity included race, racial, and 
ethnic*. Terms for disparities included disparit*, social determinant*, and social condition*.  
These search terms identified a total of 1,913 results through PubMed. 
Verification of Inclusion Criteria 
 Bibliographic details and abstracts from resulting citations were downloaded. One 
reviewer screened all citations based on the abstract to identify studies meeting inclusion criteria. 
The reviewer retrieved full texts for any studies whose inclusion could not be determined 
through information provided in the abstract. 
 Of the 1,913 results, 969 were found to meet inclusion criteria. A simple random sample 
of 192 articles (10%) identified through search terms were reviewed by a second reviewer. 
Percentage agreement (90.6%) and Κappa statistics (K = 0.803, 95% CI: 0.717-0.89) were 
calculated to reflect the degree of agreement, and the strength of agreement was considered to be 
very good. Any discrepancies between the two reviewers were resolved through discussion, and 
articles meeting inclusion criteria were eligible for the random sample of publications from 
which data would be abstracted. 
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Data Abstraction 
 Full-text articles for a simple random sample of 50 out of 969 publications meeting 
inclusion criteria were retrieved. Upon further detailed inspection, any publications that were 
found not to meet inclusion criteria were replaced with another article selected via simple 
random selection. This was the case for two out of the 50 articles. Two investigators worked to 
abstract pertinent study data into a single data collection spreadsheet created for the purposes of 
this study. First author, year, title, race/ethnicity categories, mediators, outcome, other covariates 
included in analyses, mediation analysis methods cited or used, mediation analysis results 
(including: total effects, direct effects, indirect effects, and proportion of disparity eliminated), 
and evidence of causal statements were sought from each publication. Mediation analysis 
methods were grouped into three categories: 1) Difference method; 2) Product method; 3) 
General mediation (including but not limited to G-estimation of structural nested models, 
targeted minimum loss-based estimation (TMLE), and inverse probability weighted marginal 
structural models (IPW MSMs). 
Aim 2 - Mediation Analyses 
Aim 2 consists of applying different mediation approaches to the same research question 
while using the same data, in order to determine the variation in results when using different 
mediation approaches. The research question across analyses is “How much does delivery 
payment method account for the racial/ethnic disparity in low birth weight between infants born 
to non-Hispanic white and non-Hispanic black mothers?” This research question provides an 
example of a well-documented racial disparity that a researcher might want to explain using one 
or more potentially modifiable mediators.29-32 Infants born at low birth weight (less than 2500 
grams or 5.5 pounds) are at increased risk of developmental delays, long-term complications, and 
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infant death. Low birth weight infants are often also born preterm (before 37 completed weeks of 
gestation), but they could have also experienced fetal growth restriction. Preterm birth and fetal 
growth restriction can be associated with infection, maternal medical conditions, exposure to 
tobacco smoke, and inadequate maternal weight gain during pregnancy. There exists a national 
disparity in low birth weight, as 13.2% of infants born to non-Hispanic Black mothers and 7.0% 
of infants born to non-Hispanic White mothers are low birth weight.32 Previous studies 
attempting to explain the racial disparity in low birth weight have controlled for variables such as 
maternal health,33,34 stress,29,35 and socioeconomic variables such as using government insurance 
to pay for birth.35 As a potentially modifiable “downstream” factor, payment method for delivery 
is associated with race/ethnicity and in turn has a potential association with the outcome of low 
birth weight. 
Analyses were conducted on a sample from the 2006-2010 and 2011-2013 waves of the 
National Survey of Family Growth (NSFG), a nationally representative survey of individuals age 
15-44 years in the United States. The NSFG waves 2006-2010 and 2011-2013 contain 
information on 30,035 pregnancies. As illustrated in Figure 3, analyses were limited to singleton 
livebirths, resulting in a sample of 20,666. For the purposes of these analyses, individuals of 
Hispanic and non-Hispanic Other Race/Ethnicity were also excluded, resulting in a final cohort 
of 13,611 singleton live births. With survey weights applied, these 13,611 births represent 
103,919,318 births to non-Hispanic White or non-Hispanic Black mothers in the United States. 
Race/ethnicity of mothers (non-Hispanic white (NHW) or non-Hispanic black (NHB)) was self-
reported during NSFG interviews, and will be used as the “upstream” determinant of health in 
these analyses. The outcome was low birth weight (LBW), categorized into a binary variable of  
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2,499 grams or less versus 2,500 grams or more, as according to the World Health Organization  
definition. The proposed mediator, payment method for delivery, was categorized as a binary 
 
    
NSFG
Waves 2006-2010 and 2011-2013
n = 30,035 
Presented in Tables 1A/1B
n = 20,666
Eligibility Exclusions
- Pregnancy outcome not a livebirth: - 9,073
- Not a singleton birth: -295
- Don't Know/Refused Weeks Gestation: - 1 
Final Cohort
n = 13,611 
Race/Ethnicity Exclusions
- Hispanic: - 5,994
- Non-Hispanic Other Race: - 1,061
 
Figure 3. National Survey of Family Growth Cohort Flowchart 
 
variable categorized as private insurance/own income versus Medicaid/Government Assistance 
(referent value). Other covariates included in the model to represent confounders of the mediator 
and outcome were maternal age at birth (under 20 years, 20-24 years, 25-29 years, and 30-44 
years old (referent value), maternal education (<12th grade vs HS degree or more (referent 
value)), maternal marital status (divorced/separated/cohabitating/never married versus married 
(referent value)), prenatal care (received before 20th week of gestation (referent value) versus not 
received/received after 20 weeks of gestation), gestational length (before 36 weeks gestation 
versus at least 36 weeks gestation (referent value), wantedness of pregnancy (unwanted versus 
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right time/overdue/mistimed/don’t know (referent value)), and infant born in the United States 
(yes (referent value) vs no).  
Mediation approaches demonstrated through example analyses included the difference 
method, product method, and general methods, in this case consisting of IPW MSMs and 
structural transformation. For the outcome of LBW, estimates of the NHW versus NHB disparity 
in fully adjusted models using each of the mediation approaches were compared to the risk 
difference in a model containing only race/ethnicity to estimate the counterfactual disparity 
measure (CDM) and disparity “proportion explained.” The CDM is defined as the unadjusted 
racial/ethnic disparity in LBW that was observed minus the LBW disparity that would exist if all 
mothers had paid for their delivery through own income, insurance, or a combination of own 
income/insurance. As a potential outcome, this latter disparity is impossible to observe. 
However, under given assumptions, it is possible to quantify on average using various mediation 
approaches. The proportion explained is conceptualized as the proportion of the unadjusted 
disparity that would be attenuated (or possibly exacerbated) if the mediator could be set to a 
certain level. For these example analyses, the proportion explained is calculated by subtracting 
the estimation of the race/ethnicity CDM for each mediation approach by the estimation of the 
unadjusted race/ethnicity CDM, dividing by the unadjusted race/ethnicity CDM, and multiplying 
by 100 to estimate a percent. 
Proportion Explained = (CDMunadjusted - CDMmediation approach)/ CDMunadjusted  x 100 
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3.0  RESULTS 
Aim 1 - Targeted Review 
Although articles published between 01/01/2000 and 05/18/2016 were considered 
eligible, 540 out of the 969 eligible articles identified (55.7%) and 31 of the simple random 
sample of 50 (62.0%) articles were published in 2010 or later. The majority of these 50 studies 
were conducted in the United States (43), while two were conducted in New Zealand and one 
each in Australia, Brazil, Iceland, the Netherlands, and South Africa. All studies used an 
observational cohort design, with 37 being retrospective and 13 having prospective designs. 
Studies using retrospective cohort designs employed data sources such as Medicare/Medicaid 
claims, National Health Interview Survey, National Health and Nutrition Examination Survey, 
and records from regional health-systems.  
Studies compared a variety of race/ethnicity groups, and there were many inconsistent 
coding schemes used to categorize race/ethnicity. The most common race/ethnicity 
categorization was simply white and black, as 20 studies included only these two groups for 
comparison. Multiple studies conducted in the United States also included Hispanic and/or Asian 
racial/ethnic groups, and one study each also used American Indian, Indian/Pakistani, and 
“Other” racial/ethnic groups, respectively. While some studies specified “non-Hispanic” white or 
black, others did not make this distinction. Studies conducted outside of the United States 
typically used very different racial/ethnic categories as studies conducted in the United States. 
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The two studies conducted in New Zealand included Maori, New Zealand European, and Asian 
race/ethnicities. The study conducted in South Africa categorized race/ethnicity as white, black, 
Indian, and “colored,” while the study conducted in Brazil compared white, black, and “brown” 
racial/ethnic groups. The Icelandic study compared non-mixed Icelandic, non-mixed Polish, 
mixed Polish, non-mixed Asian, and mixed Asian racial/ethnic groups.  
Mediation Approaches Used 
Of the simple random sample of 50 articles, 49 used the difference method to estimate the 
effect of the proposed mediator(s) on the racial/ethnic disparity in a health outcome. The one 
study that was an exception used the generalized product method, although this was not 
explicitly stated, nor were Baron-Kenny cited. No studies used mediation approaches categorized 
as general methods. Of studies that used the difference method, 21 used multivariate logistic 
regression, 15 used multivariate linear regression, and 9 used Cox regression/Kaplan-Meier 
survival analysis. One study each employed structural equation models, multivariate path 
models, multinomial logistic regression, and chi-square tests. The one study that used the 
generalized product method employed multivariate logistic regression.  
Underlying Assumptions Required 
None of the studies identified explicitly confirmed or acknowledged any of the 
assumptions needed in order to estimate causal effects using the difference and/or product 
methods (i.e., no uncontrolled mediator-outcome confounding; no mediator-outcome 
confounders affected by the exposure; no exposure-mediator interaction on the scale of interest). 
One study by Myakovsky (2012) makes the statement “All data were examined for statistical 
assumptions,” but does not go into detail about what these assumptions were, nor are the 
assumptions for mediation analyses specifically mentioned.36 Articles by Do (2012) and Beck 
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(2014) had a greater focus on methodology of SES as a factor to explain racial/disparities and on 
decomposing racial/ethnic disparities, respectively, but these articles do not specifically address 
the assumptions necessary in order to estimate causal effects using the difference or product 
methods.37,38 Despite not addressing these assumptions, the majority of identified studies used 
language that could be interpreted as causal (43/50), using words such as “explain,” “attenuate,” 
“contribute,” and “account for” when describing the effect of the mediator on the racial/ethnic 
disparity. For example, article by Runarsdottir states that “ethnic differences in life-satisfaction 
and distress were almost fully accounted for when sociodemographic background and social 
support were controlled.”39 Studies that did not use causal language used words such as 
“associated” or used phrases such as “may have an influence,” “likely involved,” or “may 
contribute” when describing the effect of the mediator on the racial/ethnic disparity. 
Proportion Explained  
Five studies reported a version “proportion explained” of the disparity. This estimate 
connotes the amount the disparity would change if the mediator(s) were set to a certain level. 
The typical method to calculate this proportion explained involved subtracting the estimate of the 
race/ethnicity effect in the model controlling for the proposed mediator(s) from the estimate of 
the race/ethnicity effect in the crude model, and then dividing this difference by the crude model 
estimate of the race/ethnicity effect. The formula used to calculate the proportion explained 
varied across studies, as some studies compared Odds Ratios of the race/ethnicity effect while 
others compared coefficients. One study by de Hoog did not disclose the formula used to 
calculate the average proportion explained across race/ethnicity groups.40 The article by Osborne 
treats multiple proposed mediators as each explaining a percentage of the racial ethnic disparity, 
even though they were added in a hierarchical fashion.41 "We estimate that 29% of the observed 
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disparities in mortality is caused by patient comorbidities, 6% from use of endovascular repairs, 
26% due to socioeconomic factors, and 25% because black patients receive care in lower-quality 
hospitals." Since they were added hierarchically, estimates of the proportion explained by patient 
comorbidities could change in models that also control for the other proposed mediators. Authors 
later state that “still unexplained are 14% of the difference in mortality between black and non-
black patients.” Treating proportion explained in this way could be problematic, as one might 
infer that a disparity has been completely accounted for when the proportion explained reaches 
100%. However, the proportion explained is not a true proportion, as calculating the proportion 
explained treats the total effect as a constant. In actuality, the total effect can drastically change 
due to sampling variability. This can lead to very different estimates of proportion explained. 
Proportion explained can also cause problems for interpretation when estimating a value of less 
than 0% or more than 100%.42 
All of the studies included in this targeted review were attempting to explain a 
racial/ethnic disparity using modifiable mediating variables. Every study used traditional 
mediation approaches, but not one study used a mediation approach that appropriately accounts 
for the required underlying assumptions. Most notably, no study accounts for the probable 
association of the exposure (race/ethnicity) with a confounder of the mediator-outcome 
association. This assumption was not considered, so it is likely that the traditional methods were 
not appropriate, and thus estimates of the mediation effects are not accurate. It is important to 
consider the degree to which these results could be flawed by understanding the range of 
estimates that could be found through applying various mediation approaches to the same data in 
order to answer the same research question. 
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Aim 2 - Mediation Analyses 
Survey-weighted characteristics of the NSFG sample are presented in Table 1. With 
survey weights applied, the sample represents 103,919,318 births. In this sample restricted to 
NHW and NHB mothers, 77.1% of births were to NHW mothers and 22.9% were to NHB 
mothers. Over one third of mothers paid for their delivery using only Medicaid/Government 
Assistance (36.7%). Most women were in their twenties when they gave birth, but 23.6% of 
births were to mothers under 20 years old and another 17.1% of births were to mothers over 30 
years old. Nearly one sixth of mothers (14.0%) had below a 12th grade education and 47.6% were 
not married at the time of birth. Nearly all mothers had received prenatal care before the 20th 
week of gestation (95.4%), had a gestational length of at least 36 weeks (91.8%), and did not 
believe their pregnancy was unwanted (85.1%). Nearly all infants were born in the United States 
(95.4%).  
Overall, 7.7% of births were LBW, including 6.5% of births to NHW mothers 11.8% of 
births to NHB mothers. The survey-weighted unadjusted risk ratio was 1.81 (95% Confidence 
Interval (CI): 1.53, 2.14), with infants born to NHB mothers being at almost double the risk of 
LBW as infants born to NHW mothers. Births that were paid for by Medicaid/Government 
Assistance were associated with an unadjusted LBW risk difference of 0.04 and a risk ratio of 
1.68 (95% CI: 1.52, 2.01), connoting a greater risk than births paid for with insurance, own 
income, or a combination of income/insurance. Younger maternal age at birth, less than 12th 
grade education, being not married, not having prenatal care before 20th week of gestation, 
gestational length <36 weeks, unwanted pregnancy, and births outside of the United States were 
all associated with greater risk of LBW events in unadjusted bivariate analyses.  
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The estimated unadjusted LBW risk difference among births to NHB and NHW mothers 
and CDMs using various mediation analyses are presented in Table 3. Applying survey weights 
to a simple linear regression model containing only race/ethnicity as a predictor resulted in an 
estimated 5.27 (95% CI: 3.65, 6.89) additional deaths for every 100 births to NHB mothers 
compared with births to NHW mothers. Using the difference method to account for the proposed 
mediator of payment method suggested that the disparity would be reduced 58.8% to an 
additional 2.20 (95% CI: 0.64, 3.70) deaths for every 100 births to NHB mothers if all mothers 
had a payment method of private insurance/own income (vs Government Assistance/Medicaid). 
The generalized product method estimated a proportion explained of 69.2% (CDM 1.62, 95% CI: 
-0.44, 3.68). The general methods had lower estimates of proportion explained, as using a IPW 
MSMs mediation approach suggested a proportion explained of 31.6% (CDM 3.61, 95% CI: 
1.46, 5.75), and using a Structural Transformation mediation approach suggested a proportion 
explained of 11.5% (CDM 4.66, 95% CI: 3.05, 6.28). 
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4.0  DISCUSSION 
The ultimate goal of health disparities research is not simply to measure a disparity, but 
to deepen understanding about the nature of a disparity so that some action can be taken to 
reduce it.43 While it may be impossible to intervene on complex upstream socio-demographic 
factors such as race/ethnicity, mediation analysis approaches enable researchers to demonstrate 
the effects of associated modifiable intermediate variables that in turn have an effect on a health 
outcome of interest. In theory, a well-designed intervention targeting these mediators would be 
able to reduce the disparity based on the socio-demographic factor of interest. Though these 
concepts may seem simple, applying appropriate mediation analysis techniques can become 
complicated when dealing with convoluted socio-demographic factors such as race/ethnicity.  
It is a well-established principle in the philosophy of science that no hypothesis can be 
tested in isolation, since any one hypothesis relies on the assumption that multiple other 
hypotheses are correct.44 Epidemiology is no exception, and many of the analytic techniques 
practiced in epidemiology were built upon the assumption that a multitude of underlying 
hypotheses are also correct. For example, an underlying assumption of linear regression is that 
there is a linear relationship between independent variable(s) and the dependent variable. When 
this assumption is violated, estimates resulting from linear regression are no longer appropriate 
for interpretation. In order to appropriately approach the complexity in applying mediation 
analysis techniques to disparities along socio-demographic factors, there needs to be careful 
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consideration of the underlying assumptions required in order to test a hypothesis of interest. 
Approaching mediation analyses from a causal inference framework45 can allow models to be 
depicted graphically using directed acyclic graphs (DAGs) and scrutinized for various causal 
pathways implied by the model.46 Through this causal inference lens, traditional mediation 
methods such as the difference method and product method are shown to require much more 
stringent assumptions that can be difficult to meet and impossible to verify when dealing with a 
complicated socio-demographic exposures. 
Despite these assumptions that are challenging to presume in order to appropriately 
employ traditional mediation approaches, every study included in the targeted review used 
traditional mediation approaches. Furthermore, none of these studies explicitly discussed or 
addressed any of these assumptions, even though the vast majority used language that could be 
interpreted as implying a causal effect. While using language such as “explained” and 
“accounted for” may seem innocuous, this sends a message to readers that these effects are 
causal, and thus a real-life change in these factors would result in the estimated change in the 
disparity. If these assumptions are in fact violated, these estimates could be drastically different. 
The example mediation analyses in this thesis have demonstrated important differences in 
counterfactual disparity measure according to the applied mediation analyses approaches 
applied. This is due to how these traditional and general methods account for confounding in 
different ways, as discussed on page 9. 
Employing the different mediation approaches resulted in a wide range of estimates of 
CDM and proportion explained, with the proportion explained ranging from 69.2% using the 
product method to 11.5% using structural transformation. This range of estimates is attributed to 
differences in how the traditional and general approaches handle confounding. In the case of 
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racial/ethnic disparities, perhaps the most difficult assumption to hold is that of there being no 
confounders of the mediator and outcome association that are in turn associated with the 
exposure. This is due to the nearly universal impact of race/ethnicity on downstream factors and 
outcomes. Since it is likely that there is an association between race/ethnicity and any potential 
confounders of a proposed mediator and outcome, it is likely going to be necessary to use 
mediation approaches that do not simply control for these confounders.  
In effect, IPW-MSMs account for this confounding by removing the association between 
the exposure and mediator and removing the association between confounders of the mediator-
outcome association and the mediator. Structural transformation involves transformation of the 
outcome in order to subtract the effect of the mediator from the outcome. This transformed 
outcome is then modeled against the exposure.47 An in-depth explanation of how these general 
mediation approaches account for confounders of the mediator-outcome association are 
described elsewhere.9,19,48 These approaches involve be separate assumptions required in order to 
interpret estimates as causal effects. For instance, IPW-MSMs require the assumption that the 
mediator model is correctly specified as a function of all confounders of the mediator-outcome 
association, and structural transformation requires that the outcome model is correctly specified. 
However, these assumptions may be considerably easier to believe compared to the assumption 
that race/ethnicity would not have any effect on any confounder of the mediator-outcome 
association. 
As described by Beyea and Greenland (1999), analyses should test the robustness of 
estimates by repeating them for a broad range of underlying biologic models.49 Along the lines of 
this logic, it can be important to use multiple mediation approaches in order to account for a 
variety of underlying causal models. In the results presented in the example analyses of this 
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thesis, only one of the general mediation methods (structural transformation) provided estimates 
that were statistically significantly different from both of the traditional mediation methods. 
However, both of the estimates resulted from general mediation methods (structural 
transformation and IPW MSMs), were statistically similar. This “triangulation” of estimates 
when using different approaches may further support evidence that the way that general 
mediation methods are accounting for the underlying causal model is substantially impacting the 
estimates of CDM and proportion explained. These differing estimates could represent more 
severe violation of the assumptions required in order to estimate causal effects when using 
traditional mediation methods. In the case presented in this thesis, these assumptions could have 
easily been violated, due to the hypothetical  effects that race/ethnicity have on a multitude of 
potential confounders between payment method (mediator) and low birth weight (outcome). Had 
these estimates been similar to those resulting from the application of the traditional methods, we 
may have had more evidence to assume that the required assumptions were not in violation (i.e., 
there was no relationship with the exposure and confounder(s) of the mediator-outcome 
association). Thus, using various mediation approaches to address the same question could 
elucidate on the underlying causal mechanisms involved and allow for the most appropriate 
estimates to be presented as causal effects. 
4.1 LIMITATIONS AND STRENGTHS 
As complex as the issues involved in health disparities are, so are the complexities of 
conducting a review of health disparities literature. For example, the targeted review in this 
thesis was subject to the limitation that many studies did not explicitly identify themselves as 
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mediation analyses. These studies met inclusion criteria based on their analysis goals to 
determine the impact of modifiable intermediate variables on a racial/ethnic disparity in a health 
outcome, and in effect they were using analytic approaches to answer questions of mediation, but 
we cannot know if authors were purposefully intending to determine mediation effects. 
Additionally, while literature on potential issues and required assumptions concerning traditional 
mediation methods had been published before the timeframe of studies meeting inclusion 
criteria,14,50 the publication of many impactful works concerning newly developed issues with 
traditional mediation approaches in social sciences literature occurred during this timeframe 
began.9,51-55 Given the time required for knowledge dissemination, many of the authors of studies 
included in this review would not have been expected to know the ramifications of using 
traditional mediation methods to explain disparities based on complex socio-demographic 
variables.  
To our knowledge, no methodologic reviews targeting traditional and general mediation 
techniques in questions of health disparities have been conducted. While many of the studies 
included in this review did not explicitly state that they were conducting a mediation analysis, 
studies were in effect applying analytic techniques to answer questions of mediation. Therefore, 
these studies are important to include in a methodologic review, as the conclusions drawn from 
these studies would be similar to conclusions drawn from studies with a stated goal of mediation 
analysis (i.e., the racial/ethnic disparity would change by a certain magnitude if the proposed 
mediator(s) could be set at a certain level).  
The example analyses were limited by data available on singleton livebirths in the NSFG. 
Interviews with mothers were subject to recall bias, as 68.5% of births had occurred more than 
five years previous to the interview and 38.7% of interviews had occurred more than 10 years 
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previous to the interview. In addition, the sample was limited to births to non-Hispanic White 
and non-Hispanic Black mothers race/ethnicities for purposes of interpretation, but comparisons 
are similarly limited to NHW and NHB mothers. While these limitations of the mediation 
analyses are important to consider, the primary goal of Aim 2 was to demonstrate the range of 
estimates resulting from different mediation approaches applied to answer the same research 
question using the same data. 
There are multiple strengths to using NSFG data to examine racial/ethnic disparities in 
birth outcomes. Applying survey weights to NSFG survey data allows for a sample that is 
representative of births to women living in the United States. The NSFG oversamples non-
Hispanic Black women, allowing for more precise estimates of the exposure, outcome, and 
covariates included in the Aim 2 analysis. The NSFG particularly focuses on factors that are 
pertinent in questions of birth outcomes, such as gestational length, prenatal care, and delivery 
payment method. 
4.2 CONCLUSION 
Social epidemiologists are well-aware of the importance of studying health disparities 
patterned along non-modifiable socio-demographic factors such as race/ethnicity. It is crucial to 
examine the impact of modifiable mediators in such disparities in order to understand the nature 
of such disparities and potentially develop interventions with the end goal of reducing these 
disparities. However, traditionally-used mediation approaches rely on underlying assumptions 
that are almost certainly not held when considering complex socio-demographic factors such as 
race/ethnicity. Recently, advanced analytic techniques have been applied to questions of 
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mediation in order to develop approaches that can overcome some of the required assumptions of 
traditional methods. Consideration of underlying assumptions and the use of appropriate 
mediation approaches can lead to a better understanding of health disparities and potentially 
more effective interventions. 
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APPENDIX A: TABLES 
Table 1. Characteristics of Simple Random Sample of 50 Articles 
Mediation Approach Used   
 Difference Method 49 (98%) 
 Product Method 1 (2%) 
 General Methods* 0 (0%) 
Present Estimate of Proportion of Disparity 
Explained 7 (14%) 
Used Language Inferring Causal Interpretation 43 (86%) 
Explicitly Addressed Assumptions Required to 
Assume Causal Interpretation 0 (0%) 
*G-estimation of structural nested models, targeted minimum loss-
based estimation, and inverse probability weighted marginal structural 
models 
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Table 2. Unweighted Characteristics of National Survey of Family Growth Singleton 
Livebirths and Low Birth Weight (LBW) Risk 
Variable 
Total  
(n = 103,919,318) % 
LBW Events 
(n = 8,048,388) 
LBW 
Risk 
LBW Risk 
Difference 
LBW Risk 
Ratio 
Race/Ethnicity             
 Non-Hispanic White 80,090,931 77.1% 5,234,867 0.07 (ref) (ref) 
 Non-Hispanic Black 23,828,387 22.9% 2,813,521 0.12 0.05 1.81 
Method of Payment              
 Medicaid/Govt Assistance 38,092,035 36.7% 3,964,187 0.10 0.04 1.68 
Other Forms of Payment 65,827,284 63.3% 4,084,201 0.06 (ref) (ref) 
Maternal Age at Birth             
 Under 20 years 24,483,003 23.6% 1,273,812 0.05 (ref) (ref) 
 20-24 years 28,817,465 27.7% 1,767,048 0.06 0.01 1.18 
 25-29 years 32,846,750 31.6% 2,867,579 0.09 0.04 1.68 
 30-44 years 17,772,101 17.1% 2,139,949 0.12 0.07 2.31 
Maternal Education             
 < 12th Grade 14,504,697 14.0% 1,622,856 0.11 0.04 1.56 
 12th Grade or Higher 89,414,621 86.0% 6,425,532 0.07 (ref) (ref) 
Marital Status at 
Conception             
 Married 54,433,700 52.4% 2,856,215 0.05 (ref) (ref) 
 Not Married 49,485,619 47.6% 5,192,173 0.10 0.05 2.00 
Prenatal Care             
 Yes (before 20th week of 
gestation) 99,187,703 95.4% 7,532,018 0.08 (ref) (ref) 
 No  4,731,615 4.6% 516,370 0.11 0.03 1.44 
Gestational Length              
 <36 weeks 8,525,261 8.2% 4,833,582 0.57 0.53 16.82 
 36+ weeks 95,394,057 91.8% 3,214,806 0.03 (ref) (ref) 
Wantedness of Pregnancy             
 Right Time/Overdue/ 
Mistimed/Don't Know 88,442,427 85.1% 6,432,941 0.07 (ref) (ref) 
 Unwanted 15,476,892 14.9% 1,615,447 0.10 0.03 1.44 
Born in United States             
 Yes 99,095,551 95.4% 7,502,183 0.08 (ref) (ref) 
 No 4,823,768 4.6% 546,205 0.11 0.04 1.50 
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Table 3. Weighted Counterfactual Disparity Measure (CDM) and Proportion Explained by 
Payment Method for the Low Birth Weight (LBW) Risk Difference 
  
 
  Risk Difference 
 Unadjusted Disparity 5.27 (3.65, 6.89) 
Mediation Methods CDM
a 
(95% Confidence Interval) Proportion Explained 
 Difference 2.20 (0.64, 3.70) 58.8% 
 Generalized Product 1.62 (-0.44, 3.68) 69.2% 
 IPW MSMs* 3.61 (1.46, 5.75) 31.6% 
 Structural Transformation 4.66 (3.05, 6.28) 11.5% 
*IPW MSMs: Inverse Probability-Weighted Marginal Structural Methods 
aAdjusted for maternal age, maternal education, marital status, prenatal care, gestational length, 
wantedness of pregnancy, and born in the United States 
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APPENDIX B: FIFTY STUDIES INCLUDED IN TARGETED REVIEW 
First Author Year Article Title 
Beck37 2014 Racial disparities in self-rated health: trends, explanatory factors, and the changing role of socio-demographics 
Betancourt56 2013 
Racial differences in glucose control among patients with type 2 
diabetes: a survey on dietary temptations, coping, and trust in 
physicians 
Bhatnagar57 2012 Genetic variants in platelet factor 4 modulate inflammatory and platelet activation biomarkers 
Cassidy-
Bushrow58 2012 
Race-specific relationship of birth weight and renal function 
among healthy young children 
Celeste59 2013 The role of potential mediators in racial inequalities in tooth loss: the Pro-Saude study 
Choi60 2003 Mechanisms of racial inequalities in prevalence of diarrhoea in South Africa 
Cromwell61 2005 Race/ethnic disparities in utilization of lifesaving technologies by Medicare ischemic heart disease beneficiaries 
De Franco62 2016 Racial disparity in previable birth 
De Hoog63 2011 Overweight at age 2 in a multi-ethnic cohort (ABCD study): the role of prenatal factors, birth outcomes and postnatal factors 
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Deutscher64 2010 
Black-white disparities in motor function outcomes taking into 
account patient characteristics, nontherapy ancillaries, therapy 
activities, and therapy interventions 
Do38 2012 
Does SES explain more of the black/white health gap than we 
thought? Revisiting our approach to understanding racial 
disparities in health 
Erickson65 2011 
The effect of race and ethnicity on outcomes among patients in the 
ICU: A comprehensive study involving socioeconomic status and 
resuscitation preferences 
Finch66 2000 Racial/ethnic disparities in infant mortality: the role of behavioural factors 
Flynn67 2015 
Attribution and emotions regarding health care mistreatment 
impact on continuity of care among Latino and Anglo America 
women 
Font68 2012 Examining the racial disproportionality in child protective services case decisions 
Freeman69 2011 Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival 
Hamrick70 2006 Health care disparities in postmenopausal women referred for DXA screening 
Howell71 2008 
Peginterferon pharmacokinetics in African American and 
Caucasian American patients with hepatitis C virus genotype 1 
infection 
Jolly72 2010 
Cardiac procedures among American Indians and Alaska Natives 
compared to non-Hispanic Whites hospitalized with ischemic 
heart disease in California 
Karriker-Jaffe73 2016 
Understanding associations between neighborhood socioeconomic 
status and negative consequences of  drinking: a moderated 
mediation analysis 
Katz74 2016 Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient-Reported Rheumatoid Arthritis 
Keating75 2016 
Location isn't everything: proximity, hospital characteristics, 
choice of hospital, and disparities for breast cancer surgery 
patients 
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Kershaw76 2011 Metropolitan-level racial residential segregation and black-white disparities in hypertension 
King77 2015 Decomposing differences in medical care access among cancer survivors by race and ethnicity 
Levine78 2011 Racial/Ethnic disparities in access to physician care and medications among US stroke survivors 
Levine79 2014 Acute infection contributes to racial disparities in stroke mortality  
Lorch80 2007 
Racial differences in the use of respiratory medications in 
premature infants after discharge from the neonatal intensive care 
unit 
Lotoala81 2014 Health and wellbeing of older Pacific Peoples in New Zealand 
Lynch82 2016 Race, ethnicity, psychosocial factors, and telomere length in a multicenter setting 
Menon83 2007 Amniotic fluid interleukin-1B and interleukin-8 concentrations: racial disparity in preterm birth 
Misialek84 2014 
Socioeconomic status and the incidence of atrial fibrillation (AF) 
in whites and blacks: the atherosclerosis risk in communities 
(ARIC) study 
Molina85 2008 African American and Poor Patients Have a Dramatically Worse Prognosis for Head and Neck Cancer 
Moran86 2012 
Breast Cancers in US Residing Indian-Pakistani vs non-Hispanic 
White women: comparative analysis of clinical-pathological 
features, treatment, and survival. 
Mukamel87 2006 Referrals to high-quality cardiac surgeons: patients' race and characteristics of their physicians 
Myakovsky88 2012 Perceived discrimination predicts longer time to be accepted for kidney transplant 
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Osborne89 2009 Explaining racial disparities in mortality after abdominal aortic aneurysm repair 
Patel90 2015 Racial differences in receipt of chlamydia testing among Medicaid-insured women in 2013 
Randall91 2013 
Disparities in revascularization rates after acute myocardial 
infarction between aboriginal and non-Aboriginal people in 
Australia 
Rangel92 2005 Racial and ethnic disparities in influenza vaccination among elderly adults 
Runarsdottir39 2015 Ethnic differences in youth well-being: The role of sociodemographic background and social support 
Ryu93 2013 
What factors explain disparities in mammography rates among 
Asian-American immigrant women? A population based study in 
California 
Sambamoorthi94 2003 Racial, ethnic, socioeconomic, and access disparities in the use of preventative services among women 
Sluyter95 2011 Body mass index and percent body fat in a New Zealand multi-ethnic adolescent population 
Strumpf96 2011 Racial/ethnic disparities in primary care: the role of physician-patient concordance 
Taioli97 2016 Racial disparities in esophogeal cancer survival after surgery 
Tewari98 2009 Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer 
Valdez99 2015 Racial ethnic and socioeconomic disparities in mental health in Arizona 
Waddell100 2010 Pregnancy risk among black, white, and Hispanic teen girls in New York City public schools 
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Wang101 2009 
Reduced rates of primary joint replacement for osteoarthritis in 
Italian and Greek migrants to Australia: the Melbourne 
Collaborative Cohort Study 
Warner102 2010 
Impact of neighborhood racial composition and metropolitan 
residential segregation on disparities in breast cancer stage at 
diagnosis and survival between black and white women in 
California 
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